부산대학교 도서관

Kwak L; Dana-Farber Cancer Institute, Boston, MA.; Ravi P; Dana-Farber Cancer Institute, Boston, MA.; Armstrong JG; Radiation Oncology Department, Cancer Trials Ireland, St Luke's Hospital, Dublin, Ireland.; Beckendorf V; Institut de cancérologie de Lorraine, Nancy, France.; Chin JL; Western University, London, ON, Canada.; D'Amico AV; Brigham and Women's Hospital, Boston, MA.; Dearnaley DP; The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Di Stasi SM; Department of Urology, Catholic University, Rome, Italy.; Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Lukka H; McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada.; Mottet N; Mutualite Francoise Loire, St Etienne, France.; Pommier P; Institut de Cancérologie de l'Ouest, Angers, France.; Seiferheld W; NRG Oncology, Philadelphia, PA.; Sydes MR; Medical Research Council at UCL, London, United Kingdom.; Tombal B; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Zapatero A; Department of Radiation Oncology, La Princesa University Hospital, Health Research Institute, Madrid, Spain.; Regan MM; Dana-Farber Cancer Institute, Boston, MA.; Xie W; Dana-Farber Cancer Institute, Boston, MA.; Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Mahtani R; Department of Medical Oncology, Miami Cancer Institute, Miami, FL.; Ma C; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.; DeMichele A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Cristofanilli M; Department of Medical Oncology, Weill Cornell Medicine, New York, NY.; Meisel J; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.; Miller KD; Hematology/Oncology Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.; Abdou Y; Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Riley EC; Department of Medicine, Brown Cancer Center, University of Louisville Health, Louisville, KY.; Qamar R; Aurora Cancer Care, Milwaukee, WI.; Sharma P; Department of Medical Oncology, University of Kansas Medical Center, Westwood, KS.; Reid S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Sinclair N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Faggen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Block CC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ko N; Department of Medical Oncology, Boston Medical Center, Boston, MA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Chen WY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; DeMeo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Attaya V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Okpoebo A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alberti J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Liu Y; Pfizer, La Jolla, CA.; Gauthier E; Pfizer, La Jolla, CA.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Regan MM; Harvard Medical School, Boston, MA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Einstein DJ; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Regan MM; Harvard Medical School, Boston, MA.; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.; Stevens JS; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA.; McDermott DF; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Atkins MB; Oncology, Georgetown University Medical Center, Washington, District of Columbia, USA mba41@Georgetown.edu.; Jegede OA; Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Haas NB; Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.; Mcdermott DF; Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Bilen MA; Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA.; Stein M; Columbia University, New York, New York, USA.; Columbia University/Herbert Irving Cancer Center, New York, New York, USA.; Sosman J; Northwestern University Department of Medicine, Chicago, Illinois, USA.; Alter R; John Theurer Cancer Center, Hackensack, New Jersey, USA.; Plimack ER; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Ornstein MC; Taussig Cancer Institute, Cleveland, Ohio, USA.; Hurwitz M; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.; Peace DJ; Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.; Einstein D; Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Catalano PJ; Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Hammers H; The University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Regan MM; Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Blondeaux E; U.O. Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Xie W; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA.; Carmisciano L; Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italy.; Mura S; Department of Medical Oncology, UOC Oncologia Medica, University Hospital of Sassari, Sassari, Italy.; Sanna V; Department of Medical Oncology, UOC Oncologia Medica, University Hospital of Sassari, Sassari, Italy.; De Laurentiis M; Istituto Nazionale per lo Studio e la Cura dei Tumouri, Fondazione Pascale IRCCS, Napoli, Italy.; Caputo R; Istituto Nazionale per lo Studio e la Cura dei Tumouri, Fondazione Pascale IRCCS, Napoli, Italy.; Turletti A; Medical Oncology, Ospedale Martini ASL Città di Torino, Torino, Italy.; Durando A; Breast Unit, Città della Salute e della Scienza, Ospedale S. Anna, Torino, Italy.; De Placido S; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.; De Angelis C; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.; Bisagni G; Department of Oncology and Advanced Technology, Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.; Gasparini E; Department of Oncology and Advanced Technology, Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.; Rimanti A; ASST Mantova, Azienda Ospedaliera Carlo Poma, Mantova, Italy.; Puglisi F; Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Medicine (DAME), University of Udine, Udine, Italy.; Mansutti M; Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Landucci E; Medical Oncology, S. Chiara Hospital, Pisa, Italy.; Fabi A; Precision Medicine Breast Unit, Scientific Directorate, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Arecco L; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; Perachino M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; Bruzzone M; U.O. Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Boni L; U.O. Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; Del Mastro L; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Chang E; United States Food and Drug Administration, Silver Spring, MD, United States.; Zhou J; BeiGene, Fulton, MD, United States.; Song C; United States Food and Drug Administration, Silver Spring, MD, United States.; Gittleman H; United States Food and Drug Administration, Silver Spring, MD, United States.; Fernandes L; United States Food and Drug Administration, Silver Spring, MD, United States.; Weinstock C; United States Food and Drug Administration, Silver Spring, MD, United States.; Atkins MB; Georgetown University Medical Center, Washington, DC, United States.; Agrawal S; United States Food and Drug Administration, Silver Spring, MD, United States.; Sridhara R; United States Food and Drug Administration, Silver Spring, MD, United States.; Gormley N; United States Food and Drug Administration, Silver Spring, MD, United States.; Tang S; United States Food and Drug Administration, Silver Spring, MD, United States.; Suzman DL; United States Food and Drug Administration, Silver Spring, MD, United States.; Amiri-Kordestani L; Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, United States.; Kluetz PG; Food and Drug Administration, Silver Spring, MD, United States.; Pazdur R; United States Food and Drug Administration, Silver Spring, MD, United States.; Rini BI; Vanderbilt University, Nashville, TN, United States.; McDermott DF; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Regan MM; Dana-Farber Cancer Institute, Boston, MA, United States.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Loibl S; GBG Forschungs GmbH, Neu-Isenburg; Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany.; André F; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Cancer Campus, Villejuif.; Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Barrios CH; Oncology Department, Latin American Cooperative Oncology Group and Oncoclínicas, Porto Alegre, Brazil.; Bergh J; Department of Oncology-Pathology, Bioclinicum, Karolinska Institutet and Breast Cancer Centre, Karolinska Comprehensive Cancer Centre and University Hospital, Stockholm, Sweden.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Cardoso MJ; Breast Unit, Champalimaud Foundation, Champalimaud Cancer Centre, Lisbon; Faculty of Medicine, Lisbon University, Lisbon, Portugal.; Carey LA; Division of Medical Oncology, The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Dawood S; Department of Oncology, Mediclinic City Hospital, Dubai, UAE.; Del Mastro L; Medical Oncology Clinic, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Internal Medicine and Medical Specialities, School of Medicine, University of Genoa, Genoa, Italy.; Denkert C; Institute of Pathology, Philipps-University Marburg and University Hospital Giessen and Marburg, Marburg.; Fallenberg EM; Department of Diagnostic and Interventional Radiology, School of Medicine & Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.; Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Gamal-Eldin H; Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.; Gelmon K; Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada.; Geyer CE; Department of Internal Medicine, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA.; Gnant M; Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Oncology 2 Unit, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.; Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.; Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Krug D; Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Martin M; Hospital General Universitario Gregorio Maranon, Universidad Complutense, GEICAM, Madrid, Spain.; Meattini I; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy.; Morrow M; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.; Janni W; Department of Obstetrics and Gynaecology, University of Ulm, Ulm, Germany.; Paluch-Shimon S; Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel.; Partridge A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Poortmans P; Department of Radiation Oncology, Iridium Netwerk, Antwerp; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Sparano J; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.; Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia.; Swain S; Medicine Department, Georgetown University Medical Centre and MedStar Health, Washington, USA.; Tjulandin S; N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.; Toi M; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Bunkyo-ku, Japan.; Trapani D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Tutt A; Breast Cancer Research Division, The Institute of Cancer Research, London; Comprehensive Cancer Centre, Division of Cancer Studies, Kings College London, London, UK.; Xu B; Department of Medical Oncology, National Cancer Centre/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Harbeck N; Breast Centre, Department of Obstetrics & Gynaecology and Comprehensive Cancer Centre Munich, LMU University Hospital, Munich, Germany.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Lynce F; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA. Filipa_Lynce@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Filipa_Lynce@dfci.harvard.edu.; Brigham and Women's Hospital, Boston, MA, USA. Filipa_Lynce@dfci.harvard.edu.; Stevens LE; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Li Z; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Brock JE; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Gulvady A; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Huang Y; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Nakhlis F; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Patel A; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Force JM; Duke University, Durham, NC, USA.; Haddad TC; Mayo Clinic, Rochester, MN, USA.; Ueno N; MD Anderson Cancer Center, Houston, TX, USA.; Stearns V; Johns Hopkins University, Baltimore, MA, USA.; Wolff AC; Johns Hopkins University, Baltimore, MA, USA.; Clark AS; University of Pennsylvania, Philadelphia, PA, USA.; Bellon JR; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Richardson ET; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Balko JM; Vanderbilt University Medical Center, Nashville, TN, USA.; Krop IE; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Yale Cancer Center, New Haven, CT, USA.; Winer EP; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Yale Cancer Center, New Haven, CT, USA.; Lange P; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Hwang ES; Duke University, Durham, NC, USA.; King TA; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Tolaney SM; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Thompson A; Baylor College of Medicine, Houston, TX, USA.; Gupta GP; University of North Carolina, Chapel Hill, NC, USA.; Mittendorf EA; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Regan MM; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Overmoyer B; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Polyak K; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA. kornelia_polyak@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Brigham and Women's Hospital, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

McCann KE; University of California Los Angeles Medical Center, Los Angeles, CA, 90095, USA.; Goldfarb SB; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Traina TA; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Regan MM; Dana Farber Cancer Institute / Harvard Medical School, Boston, MA, 02215, USA.; Vidula N; Massachusetts General Hospital, Boston, MA, 02114, USA.; Kaklamani V; University of Texas Health Sciences Center San Antonio / MD Anderson Cancer Center, San Antonio, TX, 78229, USA. kaklamani@uthscsa.edu.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

McGregor BA; Dana Farber Cancer Institute, Harvard Medical School, Boston. Electronic address: Bradley_mcgregor@dfci.harvard.edu.; Sonpavde GP; Dana Farber Cancer Institute, Harvard Medical School, Boston; Advent Health Cancer Institute and the University of Central Florida, Orlando.; Kwak L; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Regan MM; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Gao X; Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Hvidsten H; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Mantia CM; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Wei XX; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Berchuck JE; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Berg SA; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Ravi PK; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Michaelson MD; Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Choueiri TK; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Bellmunt J; Dana Farber Cancer Institute, Harvard Medical School, Boston. Electronic address: Joaquim_Bellmunt@dfci.harvard.edu.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE